AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for SMMT is Avoid ↓; the stock is at $13.45 (-3.93% today); neutral (RSI 44); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $13.45 |
| Change today | -3.93% |
| RSI (14) | 44.07 |
| Relative volume | 1.56 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $10.7B |
| Forward P/E | 0.00 |
| 52-week high | -55.2% away |
| 52-week low | +9.9% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-Genetherapy |
| Next earnings | 7/23/2026 4:30:00 PM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns SMMT (Summit Therapeutics Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
SMMT's RSI is neutral (RSI 44). A reading above 70 is typically considered overbought and below 30 oversold.
SMMT is trading about 55% below its 52-week high and 10% above its 52-week low as of Aug 14 2026, 1:04 PM.
SMMT's next earnings date is 7/23/2026 4:30:00 PM.
SMMT is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.